Research Article

Hubungan profil lipid dan C-reactive protein (CRP) dengan derajat stenosis koroner pada penyakit jantung koroner stabil

Katarina Noviyanti , Edward Kurnia Setiawan L

Katarina Noviyanti
PPDS-1 Patologi Klinik Fakultas Kedokteran Universitas Diponegoro. Email:

Edward Kurnia Setiawan L
Bagian Patologi Klinik Fakultas Kedokteran Universitas Diponegoro
Online First: April 01, 2019 | Cite this Article
Noviyanti, K., Setiawan L, E. 2019. Hubungan profil lipid dan C-reactive protein (CRP) dengan derajat stenosis koroner pada penyakit jantung koroner stabil. Intisari Sains Medis 10(1). DOI:10.15562/ism.v10i1.332

Background: Inflammation and dyslipidemia play an important role in the formation of atherosclerotic plaques in stable coronary artery disease (SCAD). The stenosis degree indicates a visual evaluation of the percentage reduction of coronary diameter compare to normal coronary. This study aims to determine the correlation of lipid profiles, CRP with the stenosis degree in SCAD.

Methods: Cross sectional study was carried in 31 patients with SCAD who had coronary angiography at Dr. Kariadi. The study used secondary data from February - March 2018 at Dr. Kariadi Semarang. Secondary data included levels of total cholesterol, LDL, HDL, triglycerides and CRP. The stenosis degree was obtained from coronary angiography in percentage units. Statistical analysis used Spearman Correlation test, p < 0,05 was considered significant.

Result: Median (min-max) levels of total cholesterol, HDL, LDL, triglycerides, CRP and stenosis degrees respectively are 156 (104-283), 41 (13-67), 102 (60-190), 116 (60- 216), 1.50 (0.50-6.54), 70 (20-100). Correlation of total cholesterol, HDL, LDL, triglycerides and CRP levels with a degree of coronary stenosis are (r = 0.123; p = 0.511), (r = -0.132; p = 0.479), (r = 0.073; p = 0.697), (r = 0.117; p = 0.531), (r = 0.026; p = 0.891).

Conclusion: There are no significant correlation between lipid profiles, CRP with stenosis degree in SCAD. The effect of statin drugs has an effect on dyslipidemia and as an anti-inflammatory.


Santulli G. Epidemiology of cardiovascular disease in the 21 st century: updated numbers and updated facts. J. Cardiovasc. Dis. 2013; 1(1): 1–2.

Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar (Riskesdas) 2013; 1–306.

WHO. Library Cataloguing – Publication Data. Heart: Technical packege for cardiovascular disease management in primary health care Switzerland: WHO Press; 2016.

Ghani L, Susilawati MD, Noviani H. Faktor Risiko Dominan Penyakit Jantung Koroner di Indonesia. Buletin Penelitian Kesehatan. 2016 Sept; 44(3): 153-64.

Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. ESC guidelines on the management of stable coronary artery disease. Eur. Heart J. 2013; 34(8): 2949–3003.

Dai X, Whitehead JB, Forman DE, Alexander KP. Stable ischemic heart disease in the older adults. J Geriatr Cardiol. 2016; 13(2): 109-14.

Prajapati JH, Sahoo S, Nikam T, Shah KH, Mahareya B, Parmar M. Association of high density lipoprotein with platelet to lymphocyte and neutrophil to lymphocyte ratios in coronary artery disease patients. J Lipids. 2014; 10(1): 1-8.

Khashayar P, Mohagheghi A. The Correlation Between Dyslipidemia and Coronary Artery Disease Based on Angiographic Findings in an Iranian Population. J Intern Med. 2010 Apr; 42(2): 82-5.

World Health Organization. Classification of Atherosclerotic Lession. Report of Study Group. WHO Technical Report Series, 1958; 141: 1-20

Cicek G, Açıkgöz SK, Yayla Ç, Kundi H, İleri M. White blood cell count to mean platelet volume ratio: A novel and promising prognostic marker for st-segment elevation myocardial ınfarction. Cardiol. J. 2016; 23(3): 225–35.

Kumar MD, Devi R, Kumar PS. High Sensitive C-Reactive Protein – A Risk Marker for Coronary Artery Disease. JDMS. 2012; 2(3): 28-32.

Thakur S, Gupta S, Parchwani H, Shah V, Yadav V. Hs-CRP – A potential marker for coronary heart disease. IJFALS ISSN: 2231-6345.

Knudtson M. Coronary Scoring Systems. 2014; 1–33. Diunduh dari tanggal 21 Maret 2018.

Jackson CF, Wenger NK. Cardiovascular Disease in the Elderly. Rev Esp Cardiol. 2011; 64(8): 697–712.

Murphy, E. Estrogen signaling and cardiovascular disease. Circ Res. 2011; 109(6): 687-96.

Hartopo AB, Arso IA, Setianto BY. Low Plasma Atherogenic Index Associated with Poor Prognosis in Hospitalized Patients with Acute Myocardial Infarction. Acta Medica Indones. 2016; 2(48): 106–13.

Ulucay A, Demirbag R, Yilmaz R, Unlu D, Gur M, Selek S, et al. The Relationship Between Plasma C-Reactive Protein Levels and Presence and Severity of Coronary Stenosis in Patients with Stable Angina. Angiology. 2008; 58(6): 657-62.

Rabie'ah, Carlos FK, Griselda J, Sari WP. Tatalaksana terkini dislipidemia. J. Kedokt Meditek. 2014; 20(54): 28-33.

Libby P, Ridker PM, Maseri A. Inflammaation and atherosclerosis. Circulation 105. 2002: 1135-43.

Ridker PM, Buring JE, Shih J. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98.1998: 731-3.

Auer J, Berent R, Lassnig E. C-reactive protein and coronary artery disease. Hpn Heart J. 2002; 43: 607-19.

Veselka J, Prochazkova S, Duchonova R. Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis.2002; 13: 151-4.

Horne BD, Muhlestein JB, Carlquist JF. Statin therapy, lipid levels, C-reactive protein and the survival of patient with angiographically severe coronary artery disease. J Am Coll Cardiol. 2000; 36: 1774-80.

Ridker PM, Cannon CP, Marrow D, Rifai N, Rose LM. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005; 352: 20-8.

Bonetti PO, Lerman LO, Napoli C, Lerman A. Statin effects beyond lipid lowering – are they clinically relevant?. Eur Heart J. 2003; 24: 225-48.

No Supplementary Material available for this article.
Article Views      : 66
PDF Downloads : 44